Overview

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

Status:
RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
This is an open label study to evaluate the safety and initial efficacy of intra-articular administration of Allocetra in patients with Psoriatic Arthritis (PsA).
Phase:
PHASE1
Details
Lead Sponsor:
Enlivex Therapeutics Ltd.